Fintel reports that on November 14, 2024, Piper Sandler upgraded their outlook for Campbell Soup (NasdaqGS:CPB) from Neutral ...

Piper Sandler analyst Biren Amin lowered the firm’s price target on Allogene Therapeutics (ALLO) to $9 from $11 and keeps an Overweight ...

We recently compiled a list of the 14 AI News You Should Pay Attention To. In this article, we are going to take a look at ...

Piper Sandler upgraded Campbell (CPB) to Overweight from Neutral with a price target of $56, up from $47. The firm is citing better long-term ...

Piper Sandler believes that the overall uptrend in markets remains intact, despite a Wall Street rally triggered by Donald Trump's election win taking a bit of a breather this week.  The financial ...

Piper Sandler analyst Michael S. Lavery upgraded Campbell Soup Company (NASDAQ:CPB) to Overweight from Neutral, raising the ...

Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential ...

Ahead of Nvidia's earnings report, Piper Sandler raised its price target on Nvidia from $140 to $175, maintaining its overweight rating on the stock and calling the stock its top large-cap pick, ...

Investing.com - Nvidia (NASDAQ:NVDA) is "well-positioned" to capture most of the expected growth in the market for specialized artificial intelligence-enhancing hardware in 2025, analysts at Piper ...

Nvidia (NVDA) was in the spotlight on Monday as Piper Sandler named the semiconductor giant its top large-cap pick. Read for more.

Nvidia (NVDA, Financials) experienced a slight uptick in premarket trading on Monday after Piper Sandler identified it as the top large-cap choice in the artificial intelligence accelerator market ...

Ahead of Nvidia's earnings report, Piper Sandler raised its price target on Nvidia from $140 to $175, maintaining its ...